Blueprint Medicines Corp at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everybody. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech equity analysts at Barclays. And I just want to thank everyone for taking time out of their day. And if you have questions, institutional investors can e-mail me at [email protected] or find me on Bloomberg.
And it gives me great pleasure to introduce the management team from Blueprint. And I have with me Christina Rossi, Chief Commercial Operator; and Becker Hewes, the Chief Medical Officer at Blueprint.
Questions & Answers
And I guess with that, just as an initial question, just -- and I've been asking my question -- my companies this over the last couple of days. What's the core competency do you think of Blueprint? And yes, just start there, and we dive into questions around GIST, et cetera.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |